Ogari De Castro Pacheco

This inventor holds 5 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Cristalia Produtos Quimicos Farmaceuticos Ltda., Fundacao Butantan, Genpharma Consultoria Farmaceutica E Genetica Ltda.. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ogari De Castro Pacheco. Retrieved from https://idiyas.com/inventor/ogari-de-castro-pacheco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 60.0

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Sao Paulo, BR (2009)
Itapira, BR (2013 - 2020)

Company Filing History:

4 out of 12

Cristalia Produtos Quimicos Farmaceuticos Ltda.

Genpharma Consultoria Farmaceutica E Genetica Ltda.

patent

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10597632 - Animal product-free culture medium for bacteria of the genusand a process for producing supernatant comprising one or more collagenolytic and gelatinolytic proteases (2020-03-24),

2. 10081660 - Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide (2018-09-25),

3. 9725692 - Animal product-free culture medium and a process for producing a supernatant of clostridium comprising one or more collagenolytic and gelatinolytic proteases (2017-08-08),

4. 8541395 - Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains (2013-09-24),

5. 7495105 - Non-racemic mixtures of (S) and (R) enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; related processes and pharmaceutical compositions (2009-02-24),

Title: Ogari De Castro Pacheco: Innovator in Biotechnological Solutions

Introduction

Ogari De Castro Pacheco is a notable inventor based in Itapira, Brazil. He has made significant contributions to the field of biotechnology, particularly in the development of culture media and proteases. With a total of 5 patents, his work focuses on creating innovative solutions that are both effective and environmentally friendly.

Latest Patents

One of his latest patents involves an animal product-free culture medium for bacteria of the genus, which is designed to produce proteases with collagenolytic and gelatinolytic activity. This invention emphasizes the use of non-animal origin peptones, such as vegetable peptones, along with yeast extract and essential amino acids like cysteine and arginine. Another significant patent pertains to polynucleotides and non-hemorrhagic, non-immunogenic polypeptides that exhibit selective immunosuppressive activity. These polypeptides are intended for use in pharmaceutical compositions aimed at preventing or treating various conditions that require immunosuppression, including inflammatory, autoimmune, allergic, and infectious diseases.

Career Highlights

Throughout his career, Ogari has worked with prominent companies such as Cristalia Produtos Quimicos Farmaceuticos Ltda. and Fundação Butantan. His expertise in biotechnology has allowed him to contribute to advancements in pharmaceutical applications and research.

Collaborations

Ogari has collaborated with notable professionals in his field, including Roberto Carlos Debom Moreira and Marcos Castanheira Alegria. These partnerships have further enhanced his research and development efforts.

Conclusion

Ogari De Castro Pacheco stands out as an innovative inventor in the biotechnology sector. His contributions through patents and collaborations reflect his commitment to advancing scientific knowledge and improving health solutions.

Profile summary based on public USPTO records.